期刊文献+

影响腹膜透析生存的因素及干预策略 被引量:14

Survival influencing factors and the interventional strategy in patients with peritoneal dialysis
原文传递
导出
摘要 腹膜透析(PD)是终末期肾脏疾病(ESRD)的主要替代治疗方法之一。心血管疾病(CVD)是PD患者死亡的主要原因。慢性肾脏病(CKD)患者存在非传统的、自身疾病特有的心血管危险因素,包括贫血、矿物质代谢紊乱、炎症和氧化应激状态及蛋白质能量消耗,这些都与CKD增加的全因死亡率和心血管疾病死亡率相关。提高PD患者长期生存率的策略包括纠正传统与非传统的心血管危险因素,如血压、血糖、血脂控制,戒烟,纠正贫血、钙磷代谢紊乱,纠正炎症和氧化应激及蛋白质能量消耗,同时必须高度重视PD患者存在的可纠正的影响生存的因素,如残余肾功能、腹膜完整性和PD中心规模。 Peritoneal dialysis (PD) is one of renal replacement therapeutics for patients with end-stage renal disease (ESRD). PD patients mainly died of cardiovascular disease. Patients with chronic kidney disease (CKD) have risks of cardiovascular disorders, which are non-traditional and related to the disease itself, including anemia, mineral metabolic disturbance, inflammation, oxidative stress, and protein energy wasting. These factors are correlated with the increased mortality of all causes as well as cardiovascular causes. Strategies to improve the long-term survivals of these patients include : managing of traditional and non-traditional cardiovascular factors such as blood pressure, blood glucose, blood lipid, smoking, anemia and calcium-phosphorus metabolic disturbance;and decreasing inflammation, oxidation stress and protein energy wasting. Meanwhile, high attention should be paid to the survival influencing factors that can be corrected such as residual renal function, peritoneal integrity and size of PD centers.
作者 阳晓 余学清
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2013年第6期416-418,共3页 Chinese Journal of Practical Internal Medicine
关键词 腹膜透析 终末期肾脏疾病 持续非卧床腹膜透析 peritoneal dialysis end-stage renal disease continuous ambulatory peritoneal dialysis
  • 相关文献

参考文献5

二级参考文献88

  • 1维持性腹膜透析共识[J].中华肾脏病杂志,2006,22(8):513-516. 被引量:96
  • 2Churchill DN, Thorpe KE, Nolph KD, et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol, 1998,9:1285- 1292.
  • 3Paniagua R, Amato D, Vonesh E, et al. Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol, 2002,13:1307-1320.
  • 4Jansen MA, Termorshuizen F, Korevaar JC, et al. NECOSAD Study Group. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int, 2005,68:1199-1205.
  • 5AtesK, Nergizoglu G, Keven K, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int, 2001,60:767-776.
  • 6Davis SJ, Phillips L, Naish PF, et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrel, 2001,12: 1046-1051.
  • 7Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in poritone.al dialysis patients. Kidney Int, 2004,66:2437-2445.
  • 8del Peso G, Fernandez-Reyes MJ, Hevia C, et al. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor. Nephrol Dial Transplant, 2005,20:1201 - 1206.
  • 9Numata M, Nakayama M, Nimura S, et al. Association between an increased surface area of petitoneal microvessels and a high peritoneal solute transport rate. Petit Dial Int, 2003,23:116-122.
  • 10Rumpsfeld M, McDonald SP, Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol, 2006,17:271-278.

共引文献50

同被引文献117

引证文献14

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部